Filter Search


Europe


Location Summary Deadline
Germany Conclusion Of Non-exclusive Discount Agreements Pursuant To Section 130a Paragraph 8 Of The Social Code Book V For The Active Substances Mentioned With The Possibility Of Conclusion Within The Framework Of The So-called Open House Procedure. 2026-12-31
Germany Conclusion Not Excluding Drug Discount Agreement According To § 130a Para. 8 Sgb V By Means Of An Open House Model For The Active Substance Infliximab For Subcutaneous Injection (atc Code According To Who 2026-12-31
Germany Somatropin (nutropinaq(r)) 2026-12-31
Germany Dynamic Procurement System For Carpentry Work For Various Properties In Berlin 2026-12-31
Germany Conclusion Of A Non-exclusive Drug Discount Agreement Pursuant To Section 130a Paragraph 8 Of The Social Code Book V By Means Of An Open-house Model For The Active Ingredient Rotigotine (atc Code According To Who: N04bc09) 2026-12-31
Germany Conclusion Of Non-exclusive Discount Agreements Pursuant To Section 130a Paragraph 8/130c Paragraph 1 Social Security Code V For Medicinal Products Containing The Active Ingredient Trientine (a16ax12) Within The Framework Of A So-called Open House Model. 2026-12-31
Germany Conclusion Not Exclusive Of Drug Discount Agreement According To § 130a Para. 8 Sgb V By Means Of An Open House Model For The Active Ingredient Brinzolamide/timolol (official Atcc Code 2026-12-31
Germany Open House Original Discount Agreements 2024-13 - Apremilast 2026-12-31
Germany Conclusion Of Non-exclusive Discount Agreements Pursuant To Section 130a Paragraph 8 Of The Social Code Book V For The Active Substances Mentioned With The Possibility Of Conclusion Within The Framework Of The So-called Open House Procedure. 2026-12-31
Germany Open-house Biologika Discount Contracts 2024-12-dornase Alfa 2026-12-31
Whats app